It is all about IP; Interview with Dr Sud dated 22nd Nov -...

It is all about IP;

Interview with Dr Sud dated 22nd Nov - https://thegreenfund.com/exclusive-interview-with-cannvalate-ceo-dr-sud-agarwal

"We're about to clinically validate a product for real patients who suffer from sleep apnea. That's a really exciting place to be," Agarwal said."If someone asked me to give a financial figure, what's the dollar figure that clinical aspect is worth at the end of the road?""It would be hard to say, but I would be confident it would be in the hundreds of millions of dollars because it's never been discovered before. It's a massive, massive thing."While the potential wealth to be gained from the venture could be enormous, Dr Agarwal explains that the money isn't why he aligned with IHL:"I generally feel that IHL is going to have new chemical entities that are going to be registered, I think they're going to have four registered entities. And I want to be part of it.""It's the excitement of creating a new drug that's going to potentially have life-changing, and industry-changing effects. I want to be front page and center of it," he said.


All the best to IHL and the team for a great 2019, best wishes to all IHL investors too Looking forward to more of Dr Suds interviews during 2020.